What is the official website of Regeneron Medical ?

The official website of Regeneron Medical is https://regeneronmedical.com.

What is Regeneron Medical's cybersecurity risk score?

Regeneron Medical has an AI-generated cybersecurity risk score of 751 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Regeneron Medical experienced?

According to Rankiteo, Regeneron Medical currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Regeneron Medical been affected by any supply chain cyber incidents ?

According to Rankiteo, Regeneron Medical has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Regeneron Medical have SOC 2 Type 1 certification ?

According to Rankiteo, Regeneron Medical is not certified under SOC 2 Type 1.

Does Regeneron Medical have SOC 2 Type 2 certification ?

According to Rankiteo, Regeneron Medical does not hold a SOC 2 Type 2 certification.

Does Regeneron Medical comply with GDPR ?

According to Rankiteo, Regeneron Medical is not listed as GDPR compliant.

Does Regeneron Medical have PCI DSS certification ?

According to Rankiteo, Regeneron Medical does not currently maintain PCI DSS compliance.

Does Regeneron Medical comply with HIPAA ?

According to Rankiteo, Regeneron Medical is not compliant with HIPAA regulations.

Does Regeneron Medical have ISO 27001 certification ?

According to Rankiteo,Regeneron Medical is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Regeneron Medical operate in ?

Regeneron Medical operates primarily in the Biotechnology Research industry.

How many employees does Regeneron Medical have ?

Regeneron Medical employs approximately 0 people worldwide.

Does Regeneron Medical own any subsidiaries ?

Regeneron Medical presently has no subsidiaries across any sectors.

How many LinkedIn followers does Regeneron Medical have ?

Regeneron Medical's official LinkedIn profile has approximately 616 followers.

What is the NAICS classification code for Regeneron Medical ?

Regeneron Medical is classified under the NAICS code 541714, which corresponds to Research and Development in Biotechnology (except Nanobiotechnology).

Does Regeneron Medical have a Crunchbase profile ?

No, Regeneron Medical does not have a profile on Crunchbase.

Does Regeneron Medical have a LinkedIn profile ?

Yes, Regeneron Medical maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/regeneron-medical.

How many cybersecurity incidents has Regeneron Medical experienced ?

As of October 6, 2026, Rankiteo reports that Regeneron Medical has not experienced any cybersecurity incidents.

How many peer or competitor companies does Regeneron Medical have ?

Regeneron Medical has an estimated 4,780 peer or competitor companies worldwide.

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

Regeneron Medical

Boost Score +25 with badge (5 left)

751

/1000

Fair

776

/1000

Fair

Regeneron Medical Vendor Cyber Rating & Cyber Score

regeneronmedical.com

Add Your Compliance Badge

Regeneron Medical Affairs aims to provide the latest medical and scientific information and educational resources for US healthcare professionals. By following Regeneron Medical on LinkedIn, you confirm your status as a US healthcare professional and agree to receive scientific information intended solely for healthcare professionals. Please visit www.regeneron.com/social-media-terms for guidelines to help the online community understand how social media channels may be used by Regeneron. If you have any questions about a Regeneron product, please contact us at 1-844-REGN-MID (1-844-734-6643).

Regeneron Medical

Regeneron Medical CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

Regeneron Medical Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for Regeneron Medical

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Regeneron Medical in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Regeneron Medical in 2026.

Incident Types Regeneron Medical vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Regeneron Medical in 2026.

Incident History - Regeneron Medical (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Regeneron Medical Subsidiaries

Regeneron Medical

Biotechnology Research

Website: https://regeneronmedical.com

Company Size: 0

RegeneronBiotechnology

OxularBiotechnology

Loading…

Regeneron Medical Similar Companies

Avantor

cb avantorsciences.com

Avantor® is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve. Our global footprint enables us to serve more than 300,000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries. We set science in motion to create a better world. More than 14,500 strong, our associates are passionate about our mission to set science in motion to create a better world. We share enthusiasm for innovation, excellence, and achievement. Whether we are collaborating with our customers to advance science or solve multifaceted problems, we help them reach their goals more efficiently and effectively. Visit our website to learn more about Avantor.

Eurofins

cb eurofins.com

Since 1987, Eurofins has grown from one laboratory in Nantes, France to over 65,000 staff across a network of independent companies in 60 countries, operating over 950 laboratories. Performing over 450 million tests every year, Eurofins offers a portfolio of over 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products, as well as providing innovative clinical diagnostic testing services, as one of the leading global emerging players in specialised clinical diagnostics testing. Ever since its IPO on the French stock exchange in 1997, Eurofins has been one of the fastest growing listed European companies.

bioMérieux

biomerieux.com

A family-owned company, bioMérieux has grown to become a world leader in the field of in vitro diagnostics. Our entrepreneurial adventure, begun over a century ago, is driven by an unrelenting commitment to improve public health worldwide. Since 1963, we've been paving the way in the field of in vitro diagnostics and have contributed greatly to improving public health and making the world a healthier place. The solutions that our teams imagine, develop and manufacture are key to enable healthcare professionals and industry players to make confident decisions to improve patient outcome and ensure consumer safety.

Syneos Health

cb syneoshealth.com

Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. We bring together a talented team of professionals with a deep understanding of patient and physician behaviors and market dynamics. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. Syneos Health supports a diverse, equitable and inclusive culture that cares for colleagues, customers, patients, communities and the environment.

Fortrea

fortrea.com

Fortrea (Nasdaq: FTRE) is a leading global clinical research organization (CRO) dedicated to providing innovative clinical development solutions to the life sciences industry. With over 30 years of clinical research experience, Fortrea has evolved from Covance and Labcorp into a pureplay CRO built for biotech, biopharma, medical device and diagnostic innovators. Fortrea collaborates with both emerging and established companies to deliver agile, fit-for-purpose full service (FSO), functional service (FSP) and hybrid solutions. Fortrea provides comprehensive Phase I-IV clinical trial management, clinical pharmacology, and consulting services, backed by deep experience in more than 20 therapeutic areas. Operating in approximately 100 countries, our diverse and talented team brings scientific rigor, operational excellence, and a strong investigator site network to every trial. By combining the best of our legacy experience with forward-thinking innovation, Fortrea brings predictability to clinical trial execution and helps transform aspirations into outcomes. Together, exceptional is possible. Learn more at Fortrea.com

The National Institutes of Health

cb nih.gov

NIH is the only agency of its kind. We impact the health of the country and the world through unique and innovative medical research. Did you know that NIH is the largest public funder of biomedical research in the world, investing more than $32 billion a year to enhance life, and reduce illness and disability? NIH funded research has led to breakthroughs and new treatments, helping people live longer, healthier lives, and building the research foundation that drives discovery. Whether you are graduating with a bachelor's degree, working on your doctoral degree, entering the workforce for the first time, or changing careers, NIH offers a place for you to start and plenty of room to grow your career. When you join us, you’re not just advancing your career — you’re driving the health of our country forward. Official LinkedIn Account of the NIH. Privacy policy: http://go.usa.gov/x9svN Comment policy: https://bit.ly/3G6xq94 Engagement ≠ endorsement

CSL

cb csl.com

CSL is a leading global biopharma company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies. Today, CSL – including our businesses, CSL Behring, CSL Seqirus, and CSL Vifor – provides lifesaving products to patients in more than 100 countries and employs 29,000+ people. Our unique combination of commercial strength, R&D focus and operational excellence enables us to identify, develop and deliver innovations so our patients can live life to the fullest. See our community guidelines: https://bit.ly/3Bs17Ra

Amgen

amgen.com

Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today. Our investment in research and development has yielded a robust pipeline that builds on our existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. Amgen is one of 30 companies comprising the Dow Jones Industrial Average®, and part of the Nasdaq-100 Index®. In 2024, Amgen was named one of the “World’s Most Innovative Companies” by Fast Company and one of “America’s Best Large Employers” by Forbes. For more information, visit Amgen.com and follow us on X, LinkedIn, Instagram, TikTok, YouTube and Threads. 🔗 Community Guidelines: https://wwwext.amgen.com/community-guidelines 🔗Global Privacy Statement Directory: www.amgen.com/dp Special Advisory: Please be cautious of scam recruitment offers claiming to be from Amgen. Such scams may come from various sources, including fake websites and/or unsolicited emails and seek to obtain personal data or payment from victims by offering jobs that do not exist. Please be advised that Amgen would never ask for payment to progress a job application. When in doubt, please check to see if the position in question is posted on this website before applying. Additionally, please report any suspicious recruiting activity to https://complaint.ic3.gov/ and thank you for your assistance.

Charles River Laboratories

criver.com

At Charles River, we are guided by our strong purpose—to create healthier lives—which centers around the patients who rely on the therapeutics we help to develop, the animals in our care, to our planet, and to the passionate and skilled people who are at the heart of our organization and make it all possible. #DrugDiscovery #Biotech #Biotechnology #Pharmaceuticals #CRL

Loading…

NEWS

Regeneron Medical CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

August 11, 2025 07:00 AM

Cencora & The Lash Group Settle Data Breach Litigation for $40 Million

Cencora, The Lash Group, and their affiliates have agreed to pay $40 million to settle class action data breach litigation over a February...

Read Article

August 07, 2025 07:00 AM

Regeneron Leadership Set for Morgan Stanley, Wells Fargo Healthcare Conference Presentations

Management to share insights at prestigious healthcare conferences including Morgan Stanley and Cantor events. View complete schedule and...

Read Article

July 07, 2025 07:00 AM

Bankruptcy Court Approves Sale of 23andMe

A federal bankruptcy court has approved the sale of direct-to-consumer genetic testing company 23andMe to TTAM Research Institute.

Read Article

July 02, 2025 07:00 AM

US FDA approves Regeneron's blood cancer therapy

Regeneron Pharmaceuticals said on Wednesday the U.S. Food and Drug Administration has approved its drug for a type of blood cancer called...

Read Article

June 02, 2025 07:00 AM

Regeneron's weight-loss drug helps patients on Wegovy preserve muscle

Regeneron said on Monday its experimental drug helped patients preserve up to 51% of lean mass and lose more fat when used in combination...

Read Article

May 21, 2025 07:00 AM

Gujarat teen behind 50+ cyberattacks on govt websites during 'Operation Sindoor' arrested by Gujarat ATS

Gujarat ATS arrested Jasim Shahnawaz Ansari, an 18-year-old, for alleged cyber terrorism, including DDoS attacks on over 50 Indian...

Read Article

May 19, 2025 07:00 AM

Regeneron to buy bankrupt 23andMe, vows ethical use of customer DNA data

Regeneron Pharmaceuticals said on Monday it will buy genomics firm 23andMe Holding for $256 million through a bankruptcy auction,...

Read Article

April 22, 2025 07:00 AM

Regeneron to invest over $3 billion to boost US manufacturing

Regeneron Pharmaceuticals said on Tuesday it has signed a deal worth more than $3 billion with contract drug developer Fujifilm Diosynth,...

Read Article

January 15, 2025 08:00 AM

17 health systems invest in Truveta Genome Project

The health systems, Illumina, and Regeneron have invested $320M in what Truveta calls the largest and most diverse database for patient care.

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-105761

SUMMARY

Dify is an open-source LLM app development platform. Prior to 1.16.0, the PUT /console/api/apps/<app_id>/server endpoint in api/controllers/console/app/mcp_server.py used AppMCPServerController.put() to retrieve an AppMCPServer by the client-supplied server ID without verifying that the server belonged to the requested application and tenant. An authenticated workspace member could therefore change another application's MCP server status and parameters, potentially redirecting data or disabling the service. This issue is fixed in version 1.16.0.

Published

Date2026-10-05

Updated

Date2026-10-05

RISK INFORMATION (Score: 7.1)

cvss3

Base Score: 7.1

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:H/A:L

Impact Score

4.2

Exploitability

2.8

REFERENCES

CVE-2026-105760

SUMMARY

vLLM is an inference and serving engine for large language models. Prior to 0.30.0, a caller can use the request-level media_io_kwargs field to select the GLMGA video backend and supply large values for the fps and max_frames options without a strict work ceiling. GLMGA constructs and deduplicates an attacker-sized pre-decode frame-index list, allowing a compact request and tiny valid video to consume disproportionate CPU time and memory in the shared media-loading executor. This issue is fixed in version 0.30.0.

Published

Date2026-10-05

Updated

Date2026-10-05

RISK INFORMATION (Score: 5.3)

cvss3

Base Score: 5.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:L

Impact Score

1.4

Exploitability

3.9

REFERENCES

CVE-2026-105759

SUMMARY

vLLM is an inference and serving engine for large language models. Prior to 0.30.0, the Rust frontend's track_http_metrics middleware records the raw HTTP method token as a Prometheus label for requests reaching registered routes. An unauthenticated attacker can send unique arbitrary method tokens to unguarded routes such as /tokenize, causing Prometheus's Family::get_or_create function to permanently create counter and histogram label sets. Those label sets increase process memory usage and enlarge the /metrics response until the service or monitoring path is exhausted. This issue is fixed in version 0.30.0.

Published

Date2026-10-05

Updated

Date2026-10-05

RISK INFORMATION (Score: 5.9)

cvss3

Base Score: 5.9

Complexity: HIGH

CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:N/I:N/A:H

Impact Score

3.6

Exploitability

2.2

REFERENCES

CVE-2026-105758

SUMMARY

vLLM is an inference and serving engine for large language models. From 0.24.0 until 0.30.0, the Qwen2VLVideoBackend and Qwen3VLVideoBackend classes accept request-level values for the media_io_kwargs.video.max_frames and media_io_kwargs.video.fps fields without enforcing server-side ceilings. An unauthenticated caller can submit these values to the /tokenize endpoint, causing the sampler to decode every frame selected from attacker-controlled video input, consume disproportionate frontend memory, and potentially terminate the API process before scheduling or admission control. The Rust frontend is not affected because it rejects the media_io_kwargs field. This issue is fixed in version 0.30.0.

Published

Date2026-10-05

Updated

Date2026-10-05

RISK INFORMATION (Score: 5.3)

cvss3

Base Score: 5.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:L

Impact Score

1.4

Exploitability

3.9

REFERENCES

CVE-2026-105757

SUMMARY

vLLM is an inference and serving engine for large language models. Prior to 0.30.0, structured-output request failures can escape request-scoped validation and reach the EngineCore fatal-error path. A per-request backend mismatch can re-raise a grammar compilation exception, padding produced by the ngram_gpu speculative-decoding mode can pass a negative token to guidance validation, and the Rust frontend can admit empty structured-output values that the Python frontend rejects, allowing ordinary constrained-generation requests to terminate the shared engine. This issue is fixed in version 0.30.0.

Published

Date2026-10-05

Updated

Date2026-10-05

RISK INFORMATION (Score: 6.5)

cvss3

Base Score: 6.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:H

Impact Score

3.6

Exploitability

2.8

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…

Badge your company to reduce your risk score and your cyber insurance costs!

Trusted by insurers. Chosen by leaders.

Regeneron Medical Vendor Cyber Rating & Cyber Score

Regeneron Medical A.I CyberSecurity Scoring

Regeneron Medical CyberSecurity News & History

Regeneron Medical Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for Regeneron Medical

Incidents vs Biotechnology Research Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types Regeneron Medical vs Biotechnology Research Industry Avg (This Year)

Incident History - Regeneron Medical (X = Date, Y = Severity)

Regeneron Medical Subsidiaries

Regeneron Medical

Regeneron Medical Similar Companies

Avantor

Eurofins

bioMérieux

Syneos Health

Fortrea

The National Institutes of Health

CSL

Amgen

Charles River Laboratories

Regeneron Medical CyberSecurity News

Cencora & The Lash Group Settle Data Breach Litigation for $40 Million

Regeneron Leadership Set for Morgan Stanley, Wells Fargo Healthcare Conference Presentations

Bankruptcy Court Approves Sale of 23andMe

US FDA approves Regeneron's blood cancer therapy

Regeneron's weight-loss drug helps patients on Wegovy preserve muscle

Gujarat teen behind 50+ cyberattacks on govt websites during 'Operation Sindoor' arrested by Gujarat ATS

Regeneron to buy bankrupt 23andMe, vows ethical use of customer DNA data

Regeneron to invest over $3 billion to boost US manufacturing

17 health systems invest in Truveta Genome Project

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo

Regeneron Medical CyberSecurity News & History

Regeneron Medical Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for Regeneron Medical

Incidents vs Biotechnology Research Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types Regeneron Medical vs Biotechnology Research Industry Avg (This Year)

Incident History - Regeneron Medical (X = Date, Y = Severity)

Regeneron Medical Subsidiaries

Regeneron Medical

Regeneron Medical Similar Companies

Avantor

Eurofins

bioMérieux

Syneos Health

Fortrea

The National Institutes of Health

CSL

Amgen

Charles River Laboratories

Regeneron Medical CyberSecurity News

Cencora & The Lash Group Settle Data Breach Litigation for $40 Million

Regeneron Leadership Set for Morgan Stanley, Wells Fargo Healthcare Conference Presentations

Bankruptcy Court Approves Sale of 23andMe

US FDA approves Regeneron's blood cancer therapy

Regeneron's weight-loss drug helps patients on Wegovy preserve muscle

Gujarat teen behind 50+ cyberattacks on govt websites during 'Operation Sindoor' arrested by Gujarat ATS

Regeneron to buy bankrupt 23andMe, vows ethical use of customer DNA data

Regeneron to invest over $3 billion to boost US manufacturing

17 health systems invest in Truveta Genome Project

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo